Esmeralda Neves

Esmeralda Neves

Auto-generated profile, based on publicly available information

Esmeralda Neves

Centro Hospitalar do Porto

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2014 in Antioxidants & Redox Signaling
Verified
Journal Article
Closed access
Tiina KelkkaTiina Kelkka
Tiina Kelkka
DKDeborah Kienhöfer
Deborah Kienhöfer
MHMarkus Hoffmann
Markus Hoffmann
MLMarjo Linja
Marjo Linja
KWKajsa Wing
Kajsa Wing
Rikard HolmdahlRikard Holmdahl
Rikard Holmdahl
Aims: Chronic granulomatous disease (CGD) is a primary immunodeficiency caused by mutations in the phagocyte reactive oxygen species (ROS)–producing NOX2 enzyme complex and characterized by recurrent infections associated with hyperinflammatory and autoimmune manifestations. A translational, comparative analysis of CGD patients and the corresponding ROS-deficient Ncf1 m1J mutated mouse model was performed to reveal the molecular pathways operating in NOX2 complex deficient inflammation. Results: A prominent type I interferon (IFN) response signature that was accompanied by elevated autoantibody levels was identified in both mice and humans lacking functional NOX2 complex. To further underline the systemic lupus erythematosus (SLE)-related autoimmune process, we show that naïve Ncf1 m1J mutated mice, similar to SLE patients, suffer from inflammatory kidney disease with IgG and C3 deposits in the glomeruli. Expression analysis of germ-free Ncf1 m1J mutated mice reproduced the type I IFN signature, enabling us to conclude that the upregulated signaling pathway is of endogenous origin. Innovation: Our findings link the previously unexplained connection between ROS deficiency and increased susceptibility to autoimmunity by the discovery that activation of IFN signaling is a major pathway downstream of a deficient NOX2 complex in both mice and humans. Conclusion: We conclude that the lack of phagocyte-derived oxidative burst is associated with spontaneous autoimmunity and linked with type I IFN signature in both mice and humans. Antioxid. Redox Signal . 21, 2231–2245.

6 August 2018 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
AGAnnemarie van de Geer
Annemarie van de Geer
ANAlejandro Nieto-Patlán
Alejandro Nieto-Patlán
DKDouglas B. Kuhns
Douglas B. Kuhns
ATAnton T.J. Tool
Anton T.J. Tool
AAAndrés A. Arias
Andrés A. Arias
JBJacinta Bustamante
Jacinta Bustamante
Biallelic loss-of-function (LOF) mutations of the NCF4 gene, encoding the p40phox subunit of the phagocyte NADPH oxidase, have been described in only 1 patient. We report on 24 p40phox-deficient patients from 12 additional families in 8 countries. These patients display 8 different in-frame or out-of-frame mutations of NCF4 that are homozygous in 11 of the families and compound heterozygous in another. When overexpressed in NB4 neutrophil-like cells and EBV-transformed B cells in vitro, the mutant alleles were found to be LOF, with the exception of the p.R58C and c.120_134del alleles, which were hypomorphic. Particle-induced NADPH oxidase activity was severely impaired in the patients’ neutrophils, whereas PMA-induced dihydrorhodamine-1,2,3 (DHR) oxidation, which is widely used as a diagnostic test for chronic granulomatous disease (CGD), was normal or mildly impaired in the patients. Moreover, the NADPH oxidase activity of EBV-transformed B cells was also severely impaired, whereas that of mononuclear phagocytes was normal. Finally, the killing of Candida albicans and Aspergillus fumigatus hyphae by neutrophils was conserved in these patients, unlike in patients with CGD. The patients suffer from hyperinflammation and peripheral infections, but they do not have any of the invasive bacterial or fungal infections seen in CGD. Inherited p40phox deficiency underlies a distinctive condition, resembling a mild, atypical form of CGD.

1 November 2016 in Autoimmunity Reviews
Verified
Journal Article
Closed access
CJChristophe Jamin
Christophe Jamin
LLLucas Le Lann
Lucas Le Lann
DADamiana Alvarez-Errico
Damiana Alvarez-Errico
NBNuria Barbarroja
Nuria Barbarroja
Tineke CANTAERTTineke CANTAERT
Tineke CANTAERT
JPJacques-Olivier Pers
Jacques-Olivier Pers


1 April 2002 in Pediatric Allergy and Immunology
Verified
Journal Article
Closed access
PDF file
ILI. Lopes
I. Lopes
LML. Marques
L. Marques
ENE. Neves
E. Neves
ASA. Silva
A. Silva
MTM. Taveira
M. Taveira
EME. Martins
E. Martins

1 January 2014 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
IPIrene Pais
Irene Pais
NCNuno Correia
Nuno Correia
IPIsabel Pimentel
Isabel Pimentel
MTMaria Jose Teles
Maria Jose Teles
ENEsmeralda Neves
Esmeralda Neves
HGHenry J Greten
Henry J Greten
Chemotherapy is one of most significant therapeutic approaches to cancer. Immune system functional state is considered a major prognostic and predictive impact on the success of chemotherapy and it has an important role on patients’ psychoemotional state and quality of life. In Chinese medicine, chemotherapy is understood as “toxic cold” that may induce a progressive hypofunctional state of immune system, thus compromising the fast recovery of immunity during chemotherapy. In this study, we performed a standardized acupuncture and moxibustion protocol to enhance immunity in cancer patients undergoing chemotherapy and to assess if the improvement of immunity status correlates with a better psychoemotional state and quality of life.